Effects of COVID-19 Infection on Biochemical Parameters and Biomarkers Associated with Disease Prognosis and Severity
Acta Biochimica Iranica · 25.10.2026
DOI: 10.18502/abi.v4i2.23036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica Iranica, online erschienen am 25.10.2026. Verfasst von Hamidreza Shiri und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Objectives
COVID-19 is a disease associated with biochemical disruptions. This study aimed to evaluate changes in biochemical parameters in COVID-19 patients and to identify clinically applicable biomarkers for disease prognosis and severity assessment.
Methods
This study enrolled 155 hospitalized COVID-19 patients classified as mild (n=35), moderate (n=40), severe (n=35), or critical (n=45), along with 40 healthy controls. Serum levels of blood glucose (BG), blood urea nitrogen (BUN), creatinine (Cr), aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin (T Bil), direct bilirubin (D Bil), lactate dehydrogenase (LDH), high sensitivity C reactive protein (hs CRP), and electrolytes (Na⁺, K⁺) were measured. Logistic regression was performed to assess disease severity. Receiver operating characteristic (ROC) curve analyses were conducted to identify independent predictors and optimal cut off values for prognosis (patients vs. controls) and severity (mild vs. moderate, severe, and critical groups).
Results
All hepatic, renal, and glycemic parameters, as well as LDH and hs CRP, were elevated across all patient groups compared to controls (P < 0.001). Adjusted logistic regression identified hs CRP (odds ratio (OR) = 25.76), D Bil (OR = 4.56), Cr (OR = 3.17), and LDH (OR = 1.26) as the strongest independent predictors of increased infection severity. ROC analysis determined LDH as the best biomarker for disease prognosis (AUC = 97.72%, cut off > 317 U/L) and D Bil for disease severity (AUC = 72.81%, cut off > 0.23 mg/dL).
Conclusion
LDH and D Bil represent the most clinically useful biomarkers for COVID 19 prognosis and severity detection, respectively. These results advocate for their routine integration into standard biochemical surveillance to facilitate early risk assessment; however, broader prospective investigations with larger cohorts are essential to confirm their generalizability
Zitieren
APA
Shiri, H., Soleimani, A. A., Sarajar, B. O., Panahi, G., Habibi, S., & Nematollahi, M. H. (2026). Effects of COVID-19 Infection on Biochemical Parameters and Biomarkers Associated with Disease Prognosis and Severity. Acta Biochimica Iranica. https://doi.org/10.18502/abi.v4i2.23036
Vancouver
Shiri H, Soleimani AA, Sarajar BO, Panahi G, Habibi S, Nematollahi MH. Effects of COVID-19 Infection on Biochemical Parameters and Biomarkers Associated with Disease Prognosis and Severity. Acta Biochimica Iranica. 2026. doi:10.18502/abi.v4i2.23036
BibTeX
@article{Shiri2026,
author = {Shiri, Hamidreza and Soleimani, Ali Akbar and Sarajar, Behnam Omidi and Panahi, Ghodratollah and Habibi, Sina and Nematollahi, Mohammad Hadi},
title = {Effects of COVID-19 Infection on Biochemical Parameters and Biomarkers Associated with Disease Prognosis and Severity},
journal = {Acta Biochimica Iranica},
year = {2026},
doi = {10.18502/abi.v4i2.23036}
}
EUVIMED